Navigation Links
King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy,of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For,24-hour Blood Pressure Control

atients taking either monotherapy alone. The trial met the secondary endpoint in that SBP reduction is statistically superior with the combination compared to either monotherapy. The SBP was reduced by 18.6 mmHg with the combination compared to 11.5 mmHg with HCT 25mg (p less than 0.001) and 10.4 mmHg with ALTACE 20mg (p=0.002).

The clinical trial was a randomized, double-blind, double-dummy, parallel-arm, multicenter study evaluating the effects of combining ALTACE 20mg and HCT 25mg once a day versus the monotherapy comparator arms of the component drugs. Patients were treated for eight weeks. A total of 341 patients comprised the intention-to-treat efficacy population. Blood pressure was measured using both a semi-automatic digital blood pressure device and 24-hour ambulatory blood pressure monitor.

A copy of the poster detailing the results of the trial and presented at ASH 2007 is available on King's website at: http://www.kingpharm.com/ashposter.asp.

About ALTACE

ALTACE is the leading branded ACE inhibitor with multiple indications. ALTACE is indicated for the treatment of hypertension. ALTACE has also been shown to reduce the risk of death in stable patients who have demonstrated clinical signs of congestive heart failure within the first few days after sustaining acute myocardial infarction. Based upon the results of the landmark HOPE trial, ALTACE 10mg is also indicated in patients age 55 or over at high risk of developing a major CV event either because of a history of coronary artery disease, stroke or peripheral vascular disease or because of diabetes that is accompanied by at least one other CV risk factor (hypertension, elevated total cholesterol levels, low HDL levels, cigarette smoking, or documented microalbuminuria), to reduce the risk of stroke, myocardial infarction, or death from CV causes. ALTACE can be used in addition to other needed treatments (such as antihypertensive, antiplatelet or lipid-lowering therapies).'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:8/29/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... District of New Jersey has ... Sandoz, Inc. regarding United Therapeutics, Remodulin ® product.  In ... U.S. Patent No. 6,765,117 is both valid and enforceable ... generic product until the expiration of that patent in ...
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
(Date:8/29/2014)...  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... to release its financial results for the fiscal 2014 ... market trading ends on Tuesday, September 9, 2014. ... 4:30 p.m. U.S. EDT on Tuesday, September 9, 2014 ... the Company,s financial results, commercial partnerships, and future outlook.  ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
(Date:9/2/2014)... Squared, a well-known Buy One, Give One company, is ... For every toothbrush purchased, Smile Squared gives one to ... by my wife and me after volunteering at a ... Smile Squared. “There, we saw children who had preventable ... same children didn't own a toothbrush. We wanted to ...
(Date:9/2/2014)... fact that mechanical heart valves increase risks during and ... ROPAC registry presented for the first time today in ... W. Roos-Hesselink, co-chair with Professor Roger Hall of the ... pregnant women with a mechanical heart valve died and ... Of Pregnancy And Cardiac disease (ROPAC) is an ongoing ...
(Date:9/2/2014)... September 02, 2014 Attorney Robert M. ... 2015 "Lawyer of the Year" for Medical Malpractice Law ... Meyer PC, Boston, and has been selected for inclusion in ... one lawyer in each practice area and designated metropolitan area ... particularly impressive voting averages received during the peer-review assessments. ...
(Date:9/2/2014)... 2014 During the fall season, before ... the winter months to prevent costly damage later on. ... company, suggests these fall preventative home maintenance tips. ... frequently throughout fall to prevent build up of leaves ... rot problems, pest infestations, wet basements, foundation damage and ...
(Date:9/1/2014)... web hosting provides a Windows based server environment. There ... and the new demand has resulted in an increase ... a variety of different services at very affordable prices. ... web hosting suppliers from the USA and announced that ... webmasters who want to buy high quality WordPress hosting ...
Breaking Medicine News(10 mins):Health News:Smile Squared's Colorful Buy One, Give One Toothbrush Now Available in Schnucks Stores 2Health News:Mechanical heart valves increase pregnancy risk 2Health News:Mechanical heart valves increase pregnancy risk 3Health News:Robert Higgins Named 2015 Best Lawyers® "Lawyer of the Year" in Boston 2Health News:Northern Virginia Real Estate Company Pasquali Realty Group Suggests These Maintenance Tips for Homeowners This Fall 2Health News:SEO Hosting Review Site Top10BestSEOHosting.com: Best Windows Web Hosting Suppliers From the USA Now Unveiled 2
... lifestyle characteristics can be linked to different invasive breast ... in the open access journal Breast Cancer Research ... the condition are associated with different kinds of tumor. ... California, led a team of researchers who used data ...
... Texas, ophthalmologists recommend ten simple steps to reduce your chance ... More than 20 million Americans suffer from severe vision loss. ... simple steps that everyone can take to help their eyes ... in the future. May is Healthy Vision Month and through ...
... As a health care practitioner, Trina Hammack knew ... ovarian cancer, she knew her prognosis was bleak. ... offering effective new treatments for ovarian cancer. ... of Americans diagnosed with cancer will travel to Mexico ...
... 2009NEW YORK, May 21 New York Blood ... Valley, Brooklyn / Staten Island, and New Jersey are facing ... safe blood supply for hospital patients, including: Number One: ... , Some high school blood drives have been canceled, and ...
... moms linked to higher stress levels in adolescence , , THURSDAY, ... excessive time in child-care facilities or who had insensitive mothers ... a long-term study suggests. , The conclusion is based on ... Development , that by age 15 these children are ...
... gene showed fewer signs of condition , , THURSDAY, May 21 ... allergy-induced asthma has been identified by U.S. researchers, who said ... disease. , The researchers found that mice without the ... "When compared to normal mice, those lacking the gene for ...
Cached Medicine News:Health News:Top 10 Tips to Save Your Vision 2Health News:Top 10 Tips to Save Your Vision 3Health News:Top 10 Tips to Save Your Vision 4Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 2Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 3Health News:It's Summer; Patients Need Us to Donate Blood! 2Health News:Teen Stress May Have Roots in First Three Years of Life 2
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Quatroloc Revision Hip System...
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: